My daughter is currently on Humulin N and we are thinking about switching her to Lantus.  I was wondering if
I could get some opinions on which one is better?

Views: 5535

Reply to This

Replies to This Discussion

Humulin N (NPH) is a medium acting insulin. It has a full life of about 10-16 hours and is usually given every 8 hours to try and keep a relatively constant supply.

Lantus (Glargine) is a long acting basal insulin that lasts 20-26 hours and is usually injected once per day or in 2 divided doses. It's long actions provided a stable background of insulin throughout the day.

I am lantus and like it. I have to do the divided doses because I have horrible dawn phenomenon when I only do a single injection. Plus it allows a few hours of wiggle room for dosage. Never used NPH but from what I understand and what is in the ADA manuals/textbooks more people are turning to glargine because of its ease in dosing and allowing for better control resulting in to lower A1Cs.
I am not sure if lantus is approved for children if it is then I would go for it based on my horrid experience with NPH. The only good thing NPH is that it is cheap.
Lantus is approved for use by kids, but it has not been studied in children younger than 6 years. That does not mean that it is unsafe, only that it has just not been studied. And better is a relative term. While many people find Lantus works very well and they can use just one injection, some people do experience a peak. That may occur more often in a child, others with more experience would need to chime in.

Another difference between the two insulin's in your case may be your ability to mix. Since N can mixed with rapid insulins (whereas Lantus and Levemir cannot), you may be able to reduce the overall number of injections by combining basal/bolus injections into the same syringe at mealtimes.




From the Diabetes Hands Foundation blog...

DHF receives $200,000 grant from Novo Nordisk

Grant given to support programs aimed at bringing together people touched by diabetes for positive change BERKELEY, CA: December 4, 2014 – Diabetes Hands Foundation (DHF) has received a grant of US$200,000 from Novo Nordisk to support programs aimed at Read on! →

Guest Post: World Diabetes Day 2014 on Twitter… sifting through the data

At Symplur we track hashtags, keywords, user accounts, and pretty much anything else on Twitter that has to do with healthcare. We collect the data and then build countless ways to slice it up so that we’re able to better Read on! →

Diabetes Hands Foundation Team


Manny Hernandez
(Co-Founder, Editor, has LADA)

Emily Coles
(Head of Communities, has type 1)

Mila Ferrer
(EsTuDiabetes Community Manager, mother of a child with type 1)

Mike Lawson
(Head of Experience, has type 1)

Corinna Cornejo
(Development Manager, has type 2)

Desiree Johnson  (Administrative and Programs Assistant, has type 1)


Lead Administrator

Brian (bsc) (has type 2)


Lorraine (mother of type 1)
Marie B (has type 1)

DanP (has Type 1)

Gary (has type 2)

David (has type 2)


LIKE us on Facebook

Spread the word


This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

© 2014   A community of people touched by diabetes, run by the Diabetes Hands Foundation.

Badges  |  Contact Us  |  Terms of Service